WP Banner

Working Papers

January 2016

By Carlos Cordon, Teresa Ferreiro

Introduction: How can a company overcome a 90% drop in revenues? By using big data. But how? Where should it start? This is the situation that major Dutch healthcare company Mediq faced in 2012. It us...

Read more

January 2016

By Carlos Cordon, Teresa Ferreiro

Abstract: The value chain encompasses all the activities involved in delivering a product or service to customers. In the pharmaceutical industry, for example, that includes everything from raw...

Read more

May 2015

By Carlos Cordero, Jeanny Wildi

Executive Summary: This position paper is a collaborative effort between KPMG AG Wirtschaftsprüfungs-gesellschaft, Germany (KPMG) and IMD business school, Switzerland (IMD). The aim of the paper is to...

Read more

April 2015

By Charles Dhanaraj, Rishikesha Krishnan, Srivardhini Jha

Abstract: Our inductive study of nine European multinational enterprises (MNEs) and their R&D units in India uncovers a distinct trajectory of overseas R&D evolution, ubiquitous in emerging markets. I...

Read more

November 2014

By Carlos A. Primo Braga, Athanasios Kondis

Introduction1 It has become a cliché to say that the WTO is at a crossroads.2 After twelve years of negotiations on the so-called Doha Development...

Read more

November 2014

By Carlos A. Primo Braga

Introduction: The Doha Development Agenda (DDA) negotiations “commemorated” their twelfth anniversary in November 2013. Policymakers in industrialized nations seem to be both distracted (by  the ...

Read more

October 2014

By Jean-Pierre Lehmann, Carlos A. Primo Braga

Introduction: It is impossible to tell how historians fifty years from now will judge this first decade-and-a-half of the 21st century. Three things, however, are reasonably certain. They will note it...

Read more

January 2014

By Francisco Szekely

Full text restricted  ( The author may grant permission for the text to be released in specific cases. If you are interested, contact  our Information Center   giving your name, company and reason for...

Read more

April 2013

By Benoit F. Leleux, , Jim Pulcrano

Abstract Innovation is essential to biomedical ventures, but finding the necessary financing can be difficult for small and/or early-stage firms. For this study, 73 Swiss biomedical companies provided...

Read more